VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 452 filers reported holding VANECK VECTORS ETF TR in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,505,500 | -62.8% | 50,000 | -60.0% | 0.71% | -65.1% |
| Q1 2023 | $4,043,750 | -21.6% | 125,000 | -30.6% | 2.05% | -16.2% |
| Q4 2022 | $5,158,800 | +113.9% | 180,000 | +80.0% | 2.44% | +98.9% |
| Q3 2022 | $2,412,000 | +99.8% | 100,000 | +198.5% | 1.23% | +154.2% |
| Q4 2020 | $1,207,000 | +58.0% | 33,500 | +71.8% | 0.48% | +37.6% |
| Q3 2020 | $764,000 | -16.7% | 19,500 | -22.0% | 0.35% | -33.5% |
| Q2 2020 | $917,000 | +243.4% | 25,000 | +115.5% | 0.53% | +115.5% |
| Q1 2020 | $267,000 | -88.1% | 11,600 | -88.4% | 0.24% | -77.0% |
| Q1 2019 | $2,242,000 | +6.3% | 100,000 | 0.0% | 1.06% | -2.1% |
| Q4 2018 | $2,109,000 | – | 100,000 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |